The emerging role of physiologically-based pharmacokinetic/biopharmaceutics modeling in formulation development
Uloga fiziološki-zasnovanog farmakokinetičkog/biofarmaceutskog modelovanja u razvoju farmaceutskih preparata
Article (Published version)
Metadata
Show full item recordAbstract
Computer-based (in silico) modeling & simulation tools have been embraced in different
fields of pharmaceutics for a variety of applications. Among these, physiologically-based
pharmacokinetic/biopharmaceutics modeling (PBPK/PBBM) emerged as a particularly useful
tool in formulation development. PBPK/PBBM facilitated strategies have been increasingly
evaluated over the past few years, as demonstrated by several reports from the pharmaceutical
industry, and a number of research and review papers on this subject. Also, the leading regulatory
authorities have recently issued guidance on the use of PBPK modeling in formulation design. In
silico PBPK models can comprise different dosing routes (oral, intraoral, parenteral, inhalation,
ocular, dermal etc.), although the majority of published examples refer to modeling of oral drugs
performance. In order to facilitate the use of PBPK modeling tools, a couple of companies have
launched commercially available software such as GastroPl...us™, Simcyp™ PBPK Simulator and
PK-Sim®. This paper highlights various application fields of PBPK/PBBM modeling, along with
the basic principles, advantages and limitations of this approach, and provides relevant examples
to demonstrate the practical utility of modeling & simulation tools in different stages of
formulation development.
Računarski podržano (in silico) modelovanje se danas koristi u različitim oblastima farmaceutskih nauka, sa širokom paletom primene. Kao jedan od in silico alata, fiziološki zasnovano farmakokinetičko/biofarmaceutsko modelovanje (PBPK/PBBM) se pokazalo posebno korisnim u razvoju farmaceutskih preparata. Strategije zasnovane na PBPK/PBBM modelovanju se poslednjih godina sve više razmatraju, što se vidi iz izveštaja farmaceutskih kompanija i velikog broja publikovanih istraživačkih i revijalnih radova na ovu temu. Takođe, vodeće regulatorne agencije su nedavno izdale vodiče koji se odnose na primenu PBPK modelovanja u razvoju farmaceutskih preparata. In silico PBPK modelovanje je primenjivo za različite puteve primene leka (peroralni, (intra)oralni, parenteralni, inhalacioni, okularni, dermalni itd), mada se najveći broj primera iz literature odnosi na modelovanje bioperformansi peroralno primenjenih lekova. Kako bi olakšale primenu PBPK modelovanja, nekoliko kompanija je razvilo komerci...jalno dostupne programske pakete, kao što su GastroPlus™, Simcyp™ PBPK Simulator i PK-Sim®. U ovom radu su istaknute različite mogućnosti primene PBPK/PBBM modelovanja, uključujući osnovne principe, prednosti i ograničenja. Takođe, prikazani su odgovarajući primeri koji opisuju praktičnu primenu modelovanja i simulacija u različitim fazama razvoja leka.
Keywords:
Physiologically-based pharmacokinetic modeling (PBPK) / physiologically-based biopharmaceutics modeling (PBBM) / model informed drug development (MIDD) / drug bioperformance / fiziološki zasnovano farmakokinetičko modelovanje (PBPK) / fiziološki zasnovano biofarmaceutsko modelovanje (PBBM) / model zasnovan razvoj lekova (MIDD) / bioperformanse lekovaSource:
Arhiv za farmaciju, 2021, 71, 4, 318-335Publisher:
- Beograd : Savez farmaceutskih udruženja Srbije
Funding / projects:
Collections
Institution/Community
PharmacyTY - JOUR AU - Cvijić, Sandra AU - Ignjatović, Jelisaveta AU - Parojčić, Jelena AU - Ibrić, Svetlana PY - 2021 UR - https://farfar.pharmacy.bg.ac.rs/handle/123456789/3959 AB - Computer-based (in silico) modeling & simulation tools have been embraced in different fields of pharmaceutics for a variety of applications. Among these, physiologically-based pharmacokinetic/biopharmaceutics modeling (PBPK/PBBM) emerged as a particularly useful tool in formulation development. PBPK/PBBM facilitated strategies have been increasingly evaluated over the past few years, as demonstrated by several reports from the pharmaceutical industry, and a number of research and review papers on this subject. Also, the leading regulatory authorities have recently issued guidance on the use of PBPK modeling in formulation design. In silico PBPK models can comprise different dosing routes (oral, intraoral, parenteral, inhalation, ocular, dermal etc.), although the majority of published examples refer to modeling of oral drugs performance. In order to facilitate the use of PBPK modeling tools, a couple of companies have launched commercially available software such as GastroPlus™, Simcyp™ PBPK Simulator and PK-Sim®. This paper highlights various application fields of PBPK/PBBM modeling, along with the basic principles, advantages and limitations of this approach, and provides relevant examples to demonstrate the practical utility of modeling & simulation tools in different stages of formulation development. AB - Računarski podržano (in silico) modelovanje se danas koristi u različitim oblastima farmaceutskih nauka, sa širokom paletom primene. Kao jedan od in silico alata, fiziološki zasnovano farmakokinetičko/biofarmaceutsko modelovanje (PBPK/PBBM) se pokazalo posebno korisnim u razvoju farmaceutskih preparata. Strategije zasnovane na PBPK/PBBM modelovanju se poslednjih godina sve više razmatraju, što se vidi iz izveštaja farmaceutskih kompanija i velikog broja publikovanih istraživačkih i revijalnih radova na ovu temu. Takođe, vodeće regulatorne agencije su nedavno izdale vodiče koji se odnose na primenu PBPK modelovanja u razvoju farmaceutskih preparata. In silico PBPK modelovanje je primenjivo za različite puteve primene leka (peroralni, (intra)oralni, parenteralni, inhalacioni, okularni, dermalni itd), mada se najveći broj primera iz literature odnosi na modelovanje bioperformansi peroralno primenjenih lekova. Kako bi olakšale primenu PBPK modelovanja, nekoliko kompanija je razvilo komercijalno dostupne programske pakete, kao što su GastroPlus™, Simcyp™ PBPK Simulator i PK-Sim®. U ovom radu su istaknute različite mogućnosti primene PBPK/PBBM modelovanja, uključujući osnovne principe, prednosti i ograničenja. Takođe, prikazani su odgovarajući primeri koji opisuju praktičnu primenu modelovanja i simulacija u različitim fazama razvoja leka. PB - Beograd : Savez farmaceutskih udruženja Srbije T2 - Arhiv za farmaciju T1 - The emerging role of physiologically-based pharmacokinetic/biopharmaceutics modeling in formulation development T1 - Uloga fiziološki-zasnovanog farmakokinetičkog/biofarmaceutskog modelovanja u razvoju farmaceutskih preparata VL - 71 IS - 4 SP - 318 EP - 335 DO - 10.5937/arhfarm71-32479 ER -
@article{ author = "Cvijić, Sandra and Ignjatović, Jelisaveta and Parojčić, Jelena and Ibrić, Svetlana", year = "2021", abstract = "Computer-based (in silico) modeling & simulation tools have been embraced in different fields of pharmaceutics for a variety of applications. Among these, physiologically-based pharmacokinetic/biopharmaceutics modeling (PBPK/PBBM) emerged as a particularly useful tool in formulation development. PBPK/PBBM facilitated strategies have been increasingly evaluated over the past few years, as demonstrated by several reports from the pharmaceutical industry, and a number of research and review papers on this subject. Also, the leading regulatory authorities have recently issued guidance on the use of PBPK modeling in formulation design. In silico PBPK models can comprise different dosing routes (oral, intraoral, parenteral, inhalation, ocular, dermal etc.), although the majority of published examples refer to modeling of oral drugs performance. In order to facilitate the use of PBPK modeling tools, a couple of companies have launched commercially available software such as GastroPlus™, Simcyp™ PBPK Simulator and PK-Sim®. This paper highlights various application fields of PBPK/PBBM modeling, along with the basic principles, advantages and limitations of this approach, and provides relevant examples to demonstrate the practical utility of modeling & simulation tools in different stages of formulation development., Računarski podržano (in silico) modelovanje se danas koristi u različitim oblastima farmaceutskih nauka, sa širokom paletom primene. Kao jedan od in silico alata, fiziološki zasnovano farmakokinetičko/biofarmaceutsko modelovanje (PBPK/PBBM) se pokazalo posebno korisnim u razvoju farmaceutskih preparata. Strategije zasnovane na PBPK/PBBM modelovanju se poslednjih godina sve više razmatraju, što se vidi iz izveštaja farmaceutskih kompanija i velikog broja publikovanih istraživačkih i revijalnih radova na ovu temu. Takođe, vodeće regulatorne agencije su nedavno izdale vodiče koji se odnose na primenu PBPK modelovanja u razvoju farmaceutskih preparata. In silico PBPK modelovanje je primenjivo za različite puteve primene leka (peroralni, (intra)oralni, parenteralni, inhalacioni, okularni, dermalni itd), mada se najveći broj primera iz literature odnosi na modelovanje bioperformansi peroralno primenjenih lekova. Kako bi olakšale primenu PBPK modelovanja, nekoliko kompanija je razvilo komercijalno dostupne programske pakete, kao što su GastroPlus™, Simcyp™ PBPK Simulator i PK-Sim®. U ovom radu su istaknute različite mogućnosti primene PBPK/PBBM modelovanja, uključujući osnovne principe, prednosti i ograničenja. Takođe, prikazani su odgovarajući primeri koji opisuju praktičnu primenu modelovanja i simulacija u različitim fazama razvoja leka.", publisher = "Beograd : Savez farmaceutskih udruženja Srbije", journal = "Arhiv za farmaciju", title = "The emerging role of physiologically-based pharmacokinetic/biopharmaceutics modeling in formulation development, Uloga fiziološki-zasnovanog farmakokinetičkog/biofarmaceutskog modelovanja u razvoju farmaceutskih preparata", volume = "71", number = "4", pages = "318-335", doi = "10.5937/arhfarm71-32479" }
Cvijić, S., Ignjatović, J., Parojčić, J.,& Ibrić, S.. (2021). The emerging role of physiologically-based pharmacokinetic/biopharmaceutics modeling in formulation development. in Arhiv za farmaciju Beograd : Savez farmaceutskih udruženja Srbije., 71(4), 318-335. https://doi.org/10.5937/arhfarm71-32479
Cvijić S, Ignjatović J, Parojčić J, Ibrić S. The emerging role of physiologically-based pharmacokinetic/biopharmaceutics modeling in formulation development. in Arhiv za farmaciju. 2021;71(4):318-335. doi:10.5937/arhfarm71-32479 .
Cvijić, Sandra, Ignjatović, Jelisaveta, Parojčić, Jelena, Ibrić, Svetlana, "The emerging role of physiologically-based pharmacokinetic/biopharmaceutics modeling in formulation development" in Arhiv za farmaciju, 71, no. 4 (2021):318-335, https://doi.org/10.5937/arhfarm71-32479 . .
Related items
Showing items related by title, author, creator and subject.
-
Application of model-dependent and modelindependent methods in comparison of in vitro dissolution profiles of aspirin from Eudragit RS PO matrix tablets / Primena model-zavisnih i model-nezavisnih metoda u proceni i poređenju profila brzine rastvaranja acetilsalicilne kiseline iz matriks tableta sa Eudragit-om RS PO
Ibrić, Svetlana; Jovanović, Milica; Đurić, Zorica; Parojčić, Jelena (Savez farmaceutskih udruženja Srbije, Beograd, 2002) -
Phisicochemical characterization and safety evaluation of model vehicles based on alkyl polyglucoside emulsifier for the incorporation of NSAID / Fizičkohemijska karakterizacija i procena bezbednosti model podloga sa alkil poliglukozidnim emulgatorom za NSAIL
Jakšić, Ivana; Lukić, Milica; Rajić, Mirjana; Jončić-Savić, Katarina; Radulović, Vesna; Milić, Jela; Savić, Snežana (Savez farmaceutskih udruženja Srbije, Beograd, 2010) -
Proposed models for genetic counseling: which quality indicators by donabedian's model are more feasible? / Predloženi modeli genetskog savetovanja: koji indikatori kvaliteta Donabedijanovog modela su primenljiviji?
Lević, Marija; Krajnović, Dušanka; Marinković, Valentina (University of Nis, Faculty of Medicine, 2020)